ADHD – Patient Worthy

Beyond the Diagnosis: Otsuka’s “All of ADHD” Campaign Reframes Healthcare Provider Perspectives on a Complex Condition

Post author:Bree Clare
Post published:February 17, 2026
Post category:ADHD

Otsuka has launched an ambitious awareness initiative designed to fundamentally shift how healthcare professionals understand and approach attention-deficit/hyperactivity disorder (ADHD). As reported by FiercePharma.com, the company's "All of ADHD" campaign…

FDA Prioritizes Review of Otsuka’s Centanafadine for ADHD Treatment

Post author:Austin Newman
Post published:February 12, 2026
Post category:ADHD

The U.S. Food and Drug Administration has agreed to review Otsuka Pharmaceutical’s application for centanafadine, a new extended‑release therapy under investigation for attention‑deficit hyperactivity disorder (ADHD). The agency has granted…

Landmark Review Identifies Most Effective Evidence‑Based Treatments for ADHD

Post author:Austin Newman
Post published:January 21, 2026
Post category:ADHD

As reported by Technology, a major evidence synthesis published in The BMJ has delivered the clearest picture to date of which therapies offer the strongest short‑term benefits for people with…

Rethinking ADHD: How Brain Scans Reveal Stimulants Work Through Motivation, Not Focus

Post author:Bree Clare
Post published:January 19, 2026
Post category:ADHD

For decades, doctors have prescribed stimulant medications like Ritalin and Adderall to millions of children with ADHD, operating under the assumption that these drugs directly sharpen attention and concentration. But…

FDA Approves LumosityRx as Prescription Digital Therapeutic for Adult ADHD

Post author:Austin Newman
Post published:December 22, 2025
Post category:ADHD

Lumos Labs has received FDA 510(k) approval for LumosityRx, a prescription version of its well-known Lumosity brain training platform. As reported by Fierce BioTech, The app is now authorized for…

The Risks of Self-Diagnosing Mental Health Issues on TikTok: A Growing Concern

Post author:Bree Clare
Post published:August 15, 2025
Post category:Rare Disease

Millions of social media posts and billions of views have turned TikTok into an influential platform for mental health conversations, but experts warn that using the app to self-diagnose can…

PublicDomainPictures / Pixabay

Study: Improved Well Being for Mothers of Disabled Children Who Forgive Gratuitous Criticism

Post author:Patient Worthy Contributor
Post published:December 30, 2024
Post category:Rare Disease

The CDC reports that approximately 17% of parents in the U.S. have a disabled child. These parents not only cope with the stress that accompanies their attempts to provide stability,…

source: shutterstock.com

ADHD Drug Shortages Mean People Aren’t Getting Their Meds

Post author:Jessica Lynn
Post published:April 17, 2024
Post category:ADHD

Medication can be an essential component of managing attention deficit hyperactivity disorder (ADHD). These medications, such as Vyvanse and Adderall, can help to: Reduce symptoms like impulsivity, hyperactivity, and inattention…

source: pixabay.com

ADHD: Are Prescribed Stimulants for Children Associated with Future Substance Use?

Post author:Rose Duesterwald
Post published:July 26, 2023
Post category:ADHD

Dr. Brooke Molina and co-authors at Pittsburgh University have reassuring news for parents of children with ADHD. The team conducted an in-depth study, recently published in JAMA, that followed…

source: pixabay.com

Critics Question Whether an FDA Approved Video Game Can Treat ADHD

Post author:Rose Duesterwald
Post published:July 31, 2020
Post category:ADHD

Last month, according to an article in the Washington Post, the FDA allowed marketing of a video game as potentially beneficial to children who have been diagnosed with attention-deficit hyperactivity…

Beyond the Diagnosis: Otsuka’s “All of ADHD” Campaign Reframes Healthcare Provider Perspectives on a Complex Condition

FDA Prioritizes Review of Otsuka’s Centanafadine for ADHD Treatment

Landmark Review Identifies Most Effective Evidence‑Based Treatments for ADHD

Rethinking ADHD: How Brain Scans Reveal Stimulants Work Through Motivation, Not Focus

FDA Approves LumosityRx as Prescription Digital Therapeutic for Adult ADHD

Study: Improved Well Being for Mothers of Disabled Children Who Forgive Gratuitous Criticism

ADHD Drug Shortages Mean People Aren’t Getting Their Meds

ADHD: Are Prescribed Stimulants for Children Associated with Future Substance Use?

Critics Question Whether an FDA Approved Video Game Can Treat ADHD

Let’s Work Together!

Keep Up to Date

Learn More